A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitisPaul Rutgeerts, Sharon O’Byrne, Daniel C. Baumgart et al.|Gut|2012Cited by 151
A Phase I Study of rHuMab Beta7 in Moderate to Severe Ulcerative Colitis (UC)Paul Rutgeerts, Sharon O’Byrne, Richard N. Fedorak et al.|Gastroenterology|2011Cited by 9